Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neuroplasticity01:01

Neuroplasticity

302
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
302
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
Long-term Depression01:03

Long-term Depression

2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

316
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
316
Long-term Potentiation01:25

Long-term Potentiation

2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
2.7K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

365
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
365

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

α<sub>2</sub>-Adrenergic receptor modulates 5-HT<sub>2A</sub>-mediated behavioral effects of MDMA and psilocybin in mice.

Molecular psychiatry·2026
Same author

Objective quality assessment for precision functional MRI data.

Neuron·2026
Same author

Fronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation.

Cell·2026
Same author

Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice.

bioRxiv : the preprint server for biology·2026
Same author

Parallel processing chains span cytoarchitectures to organize association cortex.

bioRxiv : the preprint server for biology·2026
Same author

Psilocybin reshapes cortical inhibition through selective interneuron recruitment.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 7, 2025

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

3.2K

Structural neural plasticity evoked by rapid-acting antidepressant interventions.

Clara Liao1,2, Alisha N Dua3, Cassandra Wojtasiewicz1

  • 1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.

Nature Reviews. Neuroscience
|November 18, 2024
PubMed
Summary

Rapid-acting antidepressants like ketamine enhance neural plasticity by promoting dendritic spine growth in the brain. This structural rewiring offers new insights into treating major depressive disorder (MDD).

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Related Experiment Videos

Last Updated: Jun 7, 2025

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

3.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cell Biology

Background:

  • Major depressive disorder (MDD) involves impaired excitatory synapses in the prefrontal cortex.
  • Rapid antidepressant treatments (ketamine, ECT, neurostimulation) converge on enhancing neural plasticity.
  • The specific plasticity mechanisms linking treatments to synaptic restoration remain unclear.

Purpose of the Study:

  • To review preclinical evidence on how psychoactive drugs and other interventions impact neuronal structure.
  • To identify characteristics of rapid-acting antidepressants related to structural plasticity.
  • To explore the role of synaptic remodeling in understanding antidepressant mechanisms.

Main Methods:

  • Review of preclinical research over the past 15 years.
  • Comparison of longitudinal effects of various psychoactive drugs on neuronal rewiring.
  • Analysis of drug-evoked in vivo structural plasticity.

Main Results:

  • Ketamine and psychedelic drugs stimulate dendritic spine growth in cortical pyramidal neurons.
  • Rapid onset and sustained effects are key features of effective antidepressant interventions.
  • Structural plasticity offers a framework for understanding diverse antidepressant actions.

Conclusions:

  • Structural neural plasticity, particularly dendritic spine growth, is a key mechanism for rapid-acting antidepressants.
  • Synaptic remodeling provides critical insights into the neurobiology of psychoactive drugs and antidepressant interventions.
  • Further research into drug-evoked structural plasticity can guide the development of novel MDD treatments.